Free Trial

Amplifon (OTCMKTS:AMFPF) Shares Gap Up - Still a Buy?

Amplifon logo with Medical background

Key Points

  • Amplifon shares gapped up significantly from $16.11 to $18.09 prior to trading on Tuesday, with a trading volume of 280 shares.
  • Despite a miss in quarterly earnings with an EPS of $0.25 compared to the expected $0.34, Amplifon reported revenue of $698.20 million, exceeding estimates.
  • Analysts from Morgan Stanley have reissued an "overweight" rating, contributing to an average rating of "Moderate Buy" for the stock.
  • Five stocks we like better than Amplifon.

Amplifon S.p.A. (OTCMKTS:AMFPF - Get Free Report) gapped up prior to trading on Tuesday . The stock had previously closed at $16.11, but opened at $18.09. Amplifon shares last traded at $18.09, with a volume of 280 shares.

Wall Street Analysts Forecast Growth

Separately, Morgan Stanley reissued an "overweight" rating on shares of Amplifon in a report on Wednesday, June 25th. One equities research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy".

Read Our Latest Stock Analysis on Amplifon

Amplifon Stock Up 12.3%

The company has a market cap of $4.08 billion, a P/E ratio of 29.66 and a beta of 0.35. The stock has a 50-day moving average of $17.53 and a two-hundred day moving average of $20.46. The company has a debt-to-equity ratio of 1.03, a quick ratio of 0.53 and a current ratio of 0.61.

Amplifon (OTCMKTS:AMFPF - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.25 EPS for the quarter, missing analysts' consensus estimates of $0.34 by ($0.09). Amplifon had a net margin of 5.20% and a return on equity of 13.70%. The business had revenue of $698.20 million for the quarter, compared to the consensus estimate of $625.73 million.

About Amplifon

(Get Free Report)

Amplifon S.p.A. engages in the distribution of hearing solutions and the fitting of customized products that help people rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Ampli-easy, Ampli-connect, Ampli-energy, and Ampli-mini hearing devices.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amplifon Right Now?

Before you consider Amplifon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amplifon wasn't on the list.

While Amplifon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.